رجوع
مُدرج أيضًا باسم
IPSEF
OTC
نطاق اليوم
KWD 43.09
KWD 43.23
نطاق 52 أسبوعًا
KWD 25.11
KWD 49.45
حجم التداول
1
متوسط 50 يوم / 200 يوم
KWD 42.78
/
KWD 35.78
الإغلاق السابق
KWD 44.63
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 133.5 | 0.4 |
| P/B | 13.2 | 2.9 |
| ROE % | 10.0 | 3.7 |
| Net Margin % | 12.1 | 3.9 |
| Rev Growth 5Y % | 6.5 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 3.844
KWD 3.499 – KWD 4.114
|
4.8 B | 1 |
| FY2029 |
KWD 3.695
KWD 3.363 – KWD 3.954
|
4.6 B | 1 |
| FY2028 |
KWD 3.266
KWD 2.973 – KWD 3.495
|
4.6 B | 1 |
النقاط الرئيسية
Revenue grew 6.46% annually over 5 years — modest growth
Earnings grew 23.43% over the past year
ROE of 10.03% — decent returns on equity
Debt/Equity of 0.24 — conservative balance sheet
Generating 992.33M in free cash flow
P/E of 133.45 — premium valuation
النمو
Revenue Growth (5Y)
6.46%
Revenue (1Y)-1.22%
Earnings (1Y)23.43%
FCF Growth (3Y)20.54%
الجودة
Return on Equity
10.03%
ROIC9.98%
Net Margin12.09%
Op. Margin20.30%
الأمان
Debt / Equity
0.24
Current Ratio1.96
Interest Coverage20.67
التقييم
P/E Ratio
133.45
P/B Ratio13.15
EV/EBITDA78.83
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.22% | Revenue Growth (3Y) | 3.34% |
| Earnings Growth (1Y) | 23.43% | Earnings Growth (3Y) | -18.60% |
| Revenue Growth (5Y) | 6.46% | Earnings Growth (5Y) | -9.86% |
| Profitability | |||
| Revenue (TTM) | 3.53B | Net Income (TTM) | 426.96M |
| ROE | 10.03% | ROA | 6.16% |
| Gross Margin | 70.58% | Operating Margin | 20.30% |
| Net Margin | 12.09% | Free Cash Flow (TTM) | 992.33M |
| ROIC | 9.98% | FCF Growth (3Y) | 20.54% |
| Safety | |||
| Debt / Equity | 0.24 | Current Ratio | 1.96 |
| Interest Coverage | 20.67 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 133.45 | P/B Ratio | 13.15 |
| P/S Ratio | 16.14 | PEG Ratio | 1.09 |
| EV/EBITDA | 78.83 | Dividend Yield | 0.01% |
| Market Cap | 56.98B | Enterprise Value | 56.51B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.53B | 3.57B | 3.31B | 3.16B | 2.75B |
| Net Income | 426.96M | 345.90M | 644.40M | 648.60M | 646.60M |
| EPS (Diluted) | 1.28 | 1.04 | 1.85 | 1.79 | 1.89 |
| Gross Profit | 2.49B | 2.96B | 2.74B | 2.63B | 2.31B |
| Operating Income | 716.85M | 496.70M | 816.00M | 729.90M | 824.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.93B | 6.44B | 6.32B | 5.61B | 5.01B |
| Total Liabilities | 2.60B | 2.26B | 2.50B | 2.27B | 2.25B |
| Shareholders' Equity | 4.33B | 4.18B | 3.83B | 3.34B | 2.74B |
| Total Debt | 1.05B | 426.80M | 373.50M | 771.60M | 693.10M |
| Cash & Equivalents | 1.52B | 678.10M | 528.40M | 1.17B | 814.70M |
| Current Assets | 2.82B | 2.02B | 1.90B | 2.40B | 1.95B |
| Current Liabilities | 1.44B | 1.51B | 1.63B | 1.34B | 1.23B |